RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SWTX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

SpringWorks Therapeutics, Inc. stock downgraded from Sell Candidate to Strong Sell Candidate after Friday trading session.
(Updated on May 24, 2024)

Sell candidate since May 23, 2024 Loss -1.00% PDF

The SpringWorks Therapeutics, Inc. stock price fell by -1.00% on the last day (Friday, 24th May 2024) from $42.81 to $42.38. During the last trading day the stock fluctuated 3.11% from a day low at $42.16 to a day high of $43.47. The price has risen in 6 of the last 10 days and is up by 3.64% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -146 thousand shares and in total, 634 thousand shares were bought and sold for approximately $26.86 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.95% during the next 3 months and, with a 90% probability hold a price between $30.32 and $36.87 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SWTX Signals & Forecast

There are few to no technical positive signals at the moment. The SpringWorks Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $43.50 and $43.77. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 01, 2024, and so far it has fallen -9.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for SpringWorks Therapeutics, Inc. stock

SpringWorks Therapeutics, Inc. finds support from accumulated volume at $42.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.31 between high and low, or 3.11%. For the last week, the stock has had daily average volatility of 4.90%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SWTX) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect SpringWorks Therapeutics, Inc. to open at $42.67, and during the day (based on 14 day Average True Range), to move between $40.12 and $44.64, which gives a possible trading interval of +/-$2.26 (+/-5.33%) up or down from last closing price. If SpringWorks Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 10.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $42.26 (0.28%) than the resistance at $43.35 (2.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is SpringWorks Therapeutics, Inc. stock A Buy?

SpringWorks Therapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.858 Strong Sell Candidate Downgraded

Predicted Opening Price for SpringWorks Therapeutics, Inc. of Tuesday, May 28, 2024

Fair opening price May 28, 2024 Current price
$42.67 ( 0.684%) $42.38

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SWTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 43.98 3.78 %
R2 43.48 2.59 %
R1 43.17 1.87 %
Current price: 42.38
Support S1 42.17 -0.497 %
S2 41.86 -1.23 %
S3 41.36 -2.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 52.07 22.86 %
R2 48.61 14.70 %
R1 43.35 2.29 %
Current price 42.38
Support S1 42.26 -0.283%
S2 40.89 -3.52%
S3 40.10 -5.38%

FAQ

What is the symbol for SpringWorks Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for SpringWorks Therapeutics, Inc. is SWTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell SpringWorks Therapeutics, Inc. Stock?
SpringWorks Therapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy SpringWorks Therapeutics, Inc. Stock?
SpringWorks Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy SpringWorks Therapeutics, Inc. Stock.

What's the current price of SpringWorks Therapeutics, Inc. Stock?
As of the end of day on the May 24, 2024, the price of an SpringWorks Therapeutics, Inc. (SWTX) share was $42.38.

What is the 52-week high and low for SpringWorks Therapeutics, Inc. Stock?
The 52-week high for SpringWorks Therapeutics, Inc. Stock is $53.90 and the 52-week low is $18.00.

What is the market capitalization of SpringWorks Therapeutics, Inc. Stock?
As of the May 24, 2024, the market capitalization of SpringWorks Therapeutics, Inc. is 3.14B.

When is the next earnings date for SpringWorks Therapeutics, Inc.?
The upcoming earnings date for SpringWorks Therapeutics, Inc. is Aug 07, 2024.
Click to get the best stock tips daily for free!

About SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics. SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also developing mirdametinib, an oral small molecule MEK inhibitor that is in Phase 2b clinical trials for the t... SWTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT